DICLOGESIC 25 TAB. 25 mg

Negara: Yordania

Bahasa: Inggris

Sumber: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

Bahan aktif:

Diclofenac Sodium 25 mg

Tersedia dari:

شركة دار الدواء للتنمية والأستثمار - Dar Al Dawa Development and Investment Co Ltd

Kode ATC:

M01AB05

INN (Nama Internasional):

Diclofenac Sodium 25 mg

Dosis:

25 mg

Unit dalam paket:

500

Diproduksi oleh:

Dar Al Dawa Development and Investment Co Ltd/Jordan (الاردن)

Ringkasan produk:

23.58 :سعر الجمهور + الضريبة

Selebaran informasi

DICLOGESIC
®
(Diclofenac Sodium)
DESCRIPTION:
DICLOGESIC
®
(diclofenac sodium) is a non-steroidal anti-inflammatory agent with
marked anti-rheumatic, analgesic
antipyretic properties.
INACTIVE INGREDIENTS:
DICLOGESIC
®
25 & 50 TABLETS:
Silica colloidal anhydrous, microcrystalline cellulose, maize starch,
povidone,
magnesium stearate, lactose monohydrate, sodium starch glycolate,
simethicone, sodium hydroxide,
methacrylic acid ethyl acrylate copolymer, triethyl citrate, talc,
titanium dioxide, Yellow color (E104) /
DICLOGESIC
®
25
Tablets, Yellow color (E110) / DICLOGESIC
®
50
Tablets , macrogol.
DICLOGESIC
® RETARD 100 TABLETS:
Hypromellose, microcrystalline cellulose, povidone, magnesium
stearate,
talc, titanium dioxide, macrogol, brown color.
DICLOGESIC
® RETARD 100 CAPSULES:
Sucrose, maize starch, stearic acid, sodium acetate phthalate,
salified
methacrylic copolymer, macrogol, talc, lactose.
DICLOGESIC
® SUPPOSITORIES:
Silica colloidal anhydrous, L-arginine, white beeswax, hard fat.
PHARMACOLOGY:
Diclofenac is rapidly absorbed when given orally or as rectal
suppository. It is absorbed more slowly when given as
enteric coated tablet, especially when this dosage form is given with
food. Although orally administered diclofenac is
almost completely absorbed; it is subject to first-pass metabolism so
that about 50% of the drug reaches the systemic
circulation in the unchanged form. At therapeutic concentrations, more
than 99% of diclofenac is bound to plasma
proteins. Diclofenac is eliminated through metabolism and subsequent
urinary and biliary excretion of glucuronide and
sulfate conjugates of the metabolites. The terminal plasma half-life
is about 1 to 2 hours.
INDICATIONS:
Inflammatory and degenerative forms of rheumatism: rheumatoid
arthritis, juvenile rheumatoid arthritis,
ankylosing spondylitis, osteoarthritis and spondylarthritis. Painful
syndromes of the vertebral column.
Non-articular rheumatism. Acute attacks of gout. Post-traumatic and
postoperative pain, inflammation, and
swelling, e.g. follow